|
Title
Collection of plasma for fractionation from donors who are anti-HBc positive (PDF only, 98KB)
|
Update date
20 April 2026
|
|
Title
Estimated residual risk for HBV, HCV and HIV (PDF only, 229KB)
|
Update date
20 April 2026
|
|
Title
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PDF only, 100KB)
|
Update date
20 April 2026
|
|
Title
Surveillance: preparedness for emerging infectious agents (PDF only, 255KB)
|
Update date
17 March 2026
|
|
Title
Blood donation and genetic haemochromatosis (PDF only, 90KB)
|
Update date
17 February 2026
|
|
Title
The relationship between JPAC and SaBTO (PDF only, 87KB)
|
Update date
22 December 2025
|
|
Title
Usutu virus (PDF only, 130KB)
|
Update date
1 September 2025
|
|
Title
H5N1 or H5Nx Zoonotic Influenza A (PDF only, 86KB)
|
Update date
1 September 2025
|
|
Title
Ebola virus (PDF only, 96KB)
|
Update date
1 September 2025
|
|
Title
Changing whole blood donation frequency in response to blood shortages (PDF only, 147KB)
|
Update date
1 December 2024
|
|
Title
West Nile Virus (WNV) (PDF only, 193KB)
|
Update date
1 September 2024
|
|
Title
Variant Creutzfeldt-Jakob disease (vCJD) (PDF only, 241KB)
|
Update date
1 September 2024
|
|
Title
The estimated residual risk that a donation made in the infectious window period is not detected on testing: risks specific for HBV, HCV and HIV in the UK (2021-2023) (PDF only, 111KB)
|
Update date
1 September 2024
|
|
Title
Mpox virus (MPXV) (PDF only, 133KB)
|
Update date
1 September 2024
|
|
Title
Dengue virus (PDF only, 129KB)
|
Update date
1 September 2024
|
|
Title
COVID-19 vaccines and blood transfusion (including pre-deposit autologous and directed donations) (PDF only, 101KB)
|
Update date
1 September 2024
|
|
Title
SARS-CoV-2 (COVID-19) and the safety of substances of human origin (SoHO) (PDF only, 79KB)
|
Update date
1 May 2024
|
|
Title
Chikungunya virus (PDF only, 58KB)
|
Update date
1 May 2024
|
|
Title
Transgender and non-binary donors (PDF only, 220KB)
|
Update date
1 April 2024
|
|
Title
Human herpesvirus 8 (HHV-8) (PDF only, 135KB)
|
Update date
1 October 2023
|
|
Title
Zika virus (PDF only, 119KB)
|
Update date
1 September 2023
|
|
Title
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) (PDF only, 116KB)
|
Update date
1 May 2023
|
|
Title
Granulocyte therapy (PDF only, 773KB)
|
Update date
1 March 2021
|
|
Title
X-ray Irradiation of blood components (PDF only, 494KB)
|
Update date
1 June 2020
|
|
Title
Blood donor selection to minimise risk of TTI infectious agents (PDF only, 276KB)
|
Update date
1 June 2020
|
|
Title
Calcium abnormalities and apheresis donation (PDF only, 401KB)
|
Update date
1 June 2017
|